| Product NDC: | 0115-1208 |
| Proprietary Name: | DOXYCYCLINE HYCLATE |
| Non Proprietary Name: | DOXYCYCLINE HYCLATE |
| Active Ingredient(s): | 75 mg/1 & nbsp; DOXYCYCLINE HYCLATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0115-1208 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090505 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110411 |
| Package NDC: | 0115-1208-13 |
| Package Description: | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0115-1208-13) |
| NDC Code | 0115-1208-13 |
| Proprietary Name | DOXYCYCLINE HYCLATE |
| Package Description | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0115-1208-13) |
| Product NDC | 0115-1208 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DOXYCYCLINE HYCLATE |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110411 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name | DOXYCYCLINE HYCLATE |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |